143 related articles for article (PubMed ID: 11371184)
1. Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone.
Crichlow GV; Nukaga M; Doppalapudi VR; Buynak JD; Knox JR
Biochemistry; 2001 May; 40(21):6233-9. PubMed ID: 11371184
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
[TBL] [Abstract][Full Text] [Related]
3. Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.
Crichlow GV; Kuzin AP; Nukaga M; Mayama K; Sawai T; Knox JR
Biochemistry; 1999 Aug; 38(32):10256-61. PubMed ID: 10441119
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.
Lobkovsky E; Billings EM; Moews PC; Rahil J; Pratt RF; Knox JR
Biochemistry; 1994 Jun; 33(22):6762-72. PubMed ID: 8204611
[TBL] [Abstract][Full Text] [Related]
6. β-Lactamase inhibition by 7-alkylidenecephalosporin sulfones: allylic transposition and formation of an unprecedented stabilized acyl-enzyme.
Rodkey EA; McLeod DC; Bethel CR; Smith KM; Xu Y; Chai W; Che T; Carey PR; Bonomo RA; van den Akker F; Buynak JD
J Am Chem Soc; 2013 Dec; 135(49):18358-69. PubMed ID: 24219313
[TBL] [Abstract][Full Text] [Related]
7. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK
Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.
Kuzin AP; Nukaga M; Nukaga Y; Hujer A; Bonomo RA; Knox JR
Biochemistry; 2001 Feb; 40(6):1861-6. PubMed ID: 11327849
[TBL] [Abstract][Full Text] [Related]
9. Penicillin sulfone inhibitors of class D beta-lactamases.
Drawz SM; Bethel CR; Doppalapudi VR; Sheri A; Pagadala SR; Hujer AM; Skalweit MJ; Anderson VE; Chen SG; Buynak JD; Bonomo RA
Antimicrob Agents Chemother; 2010 Apr; 54(4):1414-24. PubMed ID: 20086146
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes.
Nukaga M; Kumar S; Nukaga K; Pratt RF; Knox JR
J Biol Chem; 2004 Mar; 279(10):9344-52. PubMed ID: 14660590
[TBL] [Abstract][Full Text] [Related]
11. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.
Padayatti PS; Sheri A; Totir MA; Helfand MS; Carey MP; Anderson VE; Carey PR; Bethel CR; Bonomo RA; Buynak JD; van den Akker F
J Am Chem Soc; 2006 Oct; 128(40):13235-42. PubMed ID: 17017804
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
Nagarajan R; Pratt RF
Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
[TBL] [Abstract][Full Text] [Related]
13. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O
Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648
[TBL] [Abstract][Full Text] [Related]
14. The synthesis and evaluation of 2-substituted-7-(alkylidene)cephalosporin sulfones as beta-lactamase inhibitors.
Buynak JD; Doppalapudi VR; Rao AS; Nidamarthy SD; Adam G
Bioorg Med Chem Lett; 2000 May; 10(9):847-51. PubMed ID: 10853645
[TBL] [Abstract][Full Text] [Related]
15. The synthesis and evaluation of 3-substituted-7-(alkylidene)cephalosporin sulfones as beta-lactamase inhibitors.
Buynak JD; Doppalapudi VR; Adam G
Bioorg Med Chem Lett; 2000 May; 10(9):853-7. PubMed ID: 10853646
[TBL] [Abstract][Full Text] [Related]
16. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Enterobacter cloacae 908R class C beta-lactamase bound to iodo-acetamido-phenyl boronic acid, a transition-state analogue.
Wouters J; Fonzé E; Vermeire M; Frère JM; Charlier P
Cell Mol Life Sci; 2003 Aug; 60(8):1764-73. PubMed ID: 14521155
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and mechanism of inhibition of a serine beta-lactamase by O-aryloxycarbonyl hydroxamates.
Pelto RB; Pratt RF
Biochemistry; 2008 Nov; 47(46):12037-46. PubMed ID: 18942857
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase.
Kim JY; Jung HI; An YJ; Lee JH; Kim SJ; Jeong SH; Lee KJ; Suh PG; Lee HS; Lee SH; Cha SS
Mol Microbiol; 2006 May; 60(4):907-16. PubMed ID: 16677302
[TBL] [Abstract][Full Text] [Related]
20. Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99.
Trépanier S; Knox JR; Clairoux N; Sanschagrin F; Levesque RC; Huletsky A
Antimicrob Agents Chemother; 1999 Mar; 43(3):543-8. PubMed ID: 10049265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
